Urinary Bladder Neoplasms [clinicaltrials_resource:3f8807b636cb0f9a11feae0e44c69cb1]
Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer [clinicaltrials:NCT00384891]clinicaltrials:NCT00625664clinicaltrials:NCT00710970Activity Study of Sunitinib In Metastatic Pretreated Urothelial Cancer [clinicaltrials:NCT00818350]clinicaltrials:NCT00978250clinicaltrials:NCT01261299clinicaltrials:NCT01342172clinicaltrials:NCT01435356A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors [clinicaltrials:NCT01478685]Imaging Study for FdCyd and THU Cancer Treatment [clinicaltrials:NCT01479348]clinicaltrials:NCT01688999Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study [clinicaltrials:NCT01868087]Sevoflurane Versus Desflurane for Catheter-related Bladder Discomfort [clinicaltrials:NCT02096224]Effect of Glycopyrrolate and Atropine on Catheter-Related Bladder Discomfort [clinicaltrials:NCT02228473]Radical Cystectomy, Nutrition and Convalescence [clinicaltrials:NCT02238886]Propofol and Sevoflurane for Catheter-Related Bladder Discomfort [clinicaltrials:NCT02252445]SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I [clinicaltrials:NCT02254915]clinicaltrials:NCT02350543Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer [clinicaltrials:NCT02381912]Cystoscopic Imaging Collection and Enhancement pROject [clinicaltrials:NCT02427321]Irreversible Electroporation(IRE) For Unresectable Urinary Bladder Neoplasms [clinicaltrials:NCT02430623]CIK in Treating Patients With Bladder Cancer [clinicaltrials:NCT02489890]
condition [clinicaltrials_vocabulary:condition]
A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder [clinicaltrials:NCT00001381]Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer [clinicaltrials:NCT00002490]Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer [clinicaltrials:NCT00002520]Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer [clinicaltrials:NCT00002684]Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract [clinicaltrials:NCT00002914]Paclitaxel in Treating Patients With Early-Stage Bladder Cancer [clinicaltrials:NCT00002917]Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer [clinicaltrials:NCT00002919]clinicaltrials:NCT00002949Surgery and BCG in Treating Patients With Bladder Cancer [clinicaltrials:NCT00002990]Chemotherapy in Treating Patients With Solid Tumors [clinicaltrials:NCT00003103]Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer [clinicaltrials:NCT00003105]Chemotherapy in Treating Patients With Early-Stage Bladder Cancer [clinicaltrials:NCT00003129]Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer [clinicaltrials:NCT00003133]Gene Therapy in Treating Patients With Advanced Bladder Cancer [clinicaltrials:NCT00003167]Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer [clinicaltrials:NCT00003175]Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer [clinicaltrials:NCT00003342]Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium [clinicaltrials:NCT00003376]Antineoplaston Therapy in Treating Patients With Stage IV Bladder Cancer or Stage IV Newly Diagnosed, Incurable Bladder Cancer [clinicaltrials:NCT00003452]Docetaxel in Treating Patients With Solid Tumors [clinicaltrials:NCT00003565]High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer [clinicaltrials:NCT00003623]Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer [clinicaltrials:NCT00003640]Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer [clinicaltrials:NCT00003642]Combination Chemotherapy Plus Amifostine in Treating Patients With Metastatic or Unresectable Cancer [clinicaltrials:NCT00003657]Combination Chemotherapy in Treating Patients With Bladder Cancer [clinicaltrials:NCT00003701]Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer [clinicaltrials:NCT00003725]AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer [clinicaltrials:NCT00003759]Biological Therapy in Treating Patients With Bladder Cancer [clinicaltrials:NCT00003779]Eflornithine in Treating Patients With Bladder Cancer [clinicaltrials:NCT00003814]clinicaltrials:NCT00003824clinicaltrials:NCT00003930Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer [clinicaltrials:NCT00004065]Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [clinicaltrials:NCT00004074]Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors [clinicaltrials:NCT00004095]BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer [clinicaltrials:NCT00004122]Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer [clinicaltrials:NCT00004154]clinicaltrials:NCT00004203Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer [clinicaltrials:NCT00004223]Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium [clinicaltrials:NCT00004856]4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer [clinicaltrials:NCT00005047]clinicaltrials:NCT00005086
condition browse [clinicaltrials_vocabulary:condition-browse]
A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder [clinicaltrials:NCT00001381]Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer [clinicaltrials:NCT00002490]Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer [clinicaltrials:NCT00002520]Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer [clinicaltrials:NCT00002684]Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract [clinicaltrials:NCT00002914]Paclitaxel in Treating Patients With Early-Stage Bladder Cancer [clinicaltrials:NCT00002917]Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer [clinicaltrials:NCT00002919]clinicaltrials:NCT00002949Surgery and BCG in Treating Patients With Bladder Cancer [clinicaltrials:NCT00002990]Chemotherapy in Treating Patients With Solid Tumors [clinicaltrials:NCT00003103]Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer [clinicaltrials:NCT00003105]Chemotherapy in Treating Patients With Early-Stage Bladder Cancer [clinicaltrials:NCT00003129]Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer [clinicaltrials:NCT00003133]Gene Therapy in Treating Patients With Advanced Bladder Cancer [clinicaltrials:NCT00003167]Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer [clinicaltrials:NCT00003175]Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer [clinicaltrials:NCT00003342]Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium [clinicaltrials:NCT00003376]Antineoplaston Therapy in Treating Patients With Stage IV Bladder Cancer or Stage IV Newly Diagnosed, Incurable Bladder Cancer [clinicaltrials:NCT00003452]Docetaxel in Treating Patients With Solid Tumors [clinicaltrials:NCT00003565]High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer [clinicaltrials:NCT00003623]Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer [clinicaltrials:NCT00003640]Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer [clinicaltrials:NCT00003642]Combination Chemotherapy Plus Amifostine in Treating Patients With Metastatic or Unresectable Cancer [clinicaltrials:NCT00003657]Combination Chemotherapy in Treating Patients With Bladder Cancer [clinicaltrials:NCT00003701]Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer [clinicaltrials:NCT00003725]AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer [clinicaltrials:NCT00003759]Biological Therapy in Treating Patients With Bladder Cancer [clinicaltrials:NCT00003779]Eflornithine in Treating Patients With Bladder Cancer [clinicaltrials:NCT00003814]clinicaltrials:NCT00003824clinicaltrials:NCT00003930Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer [clinicaltrials:NCT00004065]Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [clinicaltrials:NCT00004074]Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors [clinicaltrials:NCT00004095]BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer [clinicaltrials:NCT00004122]Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer [clinicaltrials:NCT00004154]clinicaltrials:NCT00004203Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer [clinicaltrials:NCT00004223]Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium [clinicaltrials:NCT00004856]4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer [clinicaltrials:NCT00005047]clinicaltrials:NCT00005086
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Urinary Bladder Neoplasms [clinicaltrials_resource:3f8807b636cb0f9a11feae0e44c69cb1]
Bio2RDF identifier
3f8807b636cb0f9a11feae0e44c69cb1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3f8807b636cb0f9a11feae0e44c69cb1
identifier
clinicaltrials_resource:3f8807b636cb0f9a11feae0e44c69cb1
title
Urinary Bladder Neoplasms
@en
type
label
Urinary Bladder Neoplasms [clinicaltrials_resource:3f8807b636cb0f9a11feae0e44c69cb1]
@en
Urinary Bladder Neoplasms